Global G Protein Coupled Receptors Market Size 2024, Forecast To 2033
8 Mar, 2024
The G-protein coupled receptors market has shown strong growth, increasing from $2.97 billion in 2023 to $3.18 billion in 2024, with a CAGR of 7.1%. This growth is attributed to advances in drug discovery, regulatory approvals, and demographic shifts. Looking forward, the market is expected to continue its growth momentum, reaching $4.09 billion by 2028, with a CAGR of 6.5%. Factors such as personalized medicine, artificial intelligence in drug discovery, and environmental considerations are anticipated to drive this growth. Furthermore, trends like biotechnology advancements and increased R&D investment are likely to shape the market, alongside collaborations and innovations in digital therapeutics.
Global G Protein Coupled Receptors Market Key Driver
The increasing prevalence of cancer fuels growth in the G-protein-coupled receptors market. Cancer's widespread impact necessitates effective treatment modalities, with GPCRs playing a crucial role in controlling cancer-related processes. Statistics from various sources, including the American Society of Clinical Oncology and the Breast Cancer Research Foundation, highlight the rising incidence of cancer, driving demand for GPCR-related therapeutics. Thus, the growing prevalence of cancer propels the G-protein-coupled receptors market forward.
Get A Free Sample Of The Global G Protein Coupled Receptors Market ReportGlobal G Protein Coupled Receptors Market Segments
The g-protein coupled receptors market covered in this report is segmented –
1) Product:Cell Lines, Detection Kits, Cell Culture Reagents, Ligands
2) Assay:CAMP Functional Assays, Calcium Functional Assays, ß-Arrestin Functional Assays, Radioligand Binding and GTP?S Functional Assays, Internalization Assays, Trafficking Assays
3) Applications:Cancer Research, CNS Research, Metabolic Research, Cardiovascular Research, Inflammation Research, Respiratory Research, Other Applications
By Geography: The countries covered in the g-protein coupled receptors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
North America was the largest region in the G-protein coupled receptors market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the g-protein coupled receptors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Major G Protein Coupled Receptors Industry Players
Pfizer Inc.; Roche Holding AG; AbbVie Inc.; Bayer AG; Novartis International AG; Sanofi SA; Bristol-Myers Squibb Company; AstraZeneca Plc; GlaxoSmithKline Plc; Danaher Corporation; Takeda Pharmaceutical Company Limited; Eli Lilly and Company; Merck KGaA; Boehringer Ingelheim; Teva Pharmaceutical Industries Ltd.; Daiichi Sankyo Company Limited; Thermo Fisher Scientific Inc.; Perkin Elmer Inc.; Qiagen N.V.; Bio-Techne Corporation; Abcam PLC; Cara Therapeutics Inc.; Sosei Heptares Ltd.; Eurofins DiscoverX Corporation; Crinetics Pharmaceuticals Inc.; Domain Therapeutics SA; Addex Pharmaceuticals Ltd.; Escient Pharmaceuticals Inc.; Structure Therapeutics; Septerna
Get The Full Global G Protein Coupled Receptors Market Report
G Protein Coupled Receptors Market Overview
G-protein coupled receptors refer to a kind of membrane receptor also known as seven-(pass)-transmembrane receptors. These are present in the cell membrane and are in charge of binding extracellular chemicals and sending signals from these substances to an intracellular molecule. GPCRs are the largest family of membrane proteins and mediate most cellular responses to hormones and neurotransmitters, and being responsible for vision, olfaction, and taste.